AGE-RELATED EYE DISEASE STUDY 2 RESEARCH GROUP.
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial. JAMA, v. 309, n. 19, p. 2005–2015, 2013.
CHEW, E.Y.; et al.
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report no. 3. JAMA Ophthalmology, v. 132, n. 2, p. 142–149, 2014.
BONE, R.A.; LANDRUM, J.T.; GUERRA, L.H.; RUIZ, C.A.
Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations. Journal of Nutrition, v. 133, n. 4, p. 992–998, 2003.
STRINGHAM, J.M.; HAMMOND, B.R.
Macular pigment and visual performance under glare conditions. Optometry and Vision Science, v. 85, n. 2, p. 82–88, 2008.
AGE-RELATED EYE DISEASE STUDY RESEARCH GROUP.
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Archives of Ophthalmology, v. 119, n. 10, p. 1417–1436, 2001.
UETA, T.; et al.
Zinc supplementation and its role in retinal antioxidant defense and visual function. Nutrients, v. 13, n. 2, p. 1–15, 2021.